Literature DB >> 14502569

Reduced cell adhesion during mitosis by threonine phosphorylation of beta1 integrin.

Katsuo Suzuki1, Kazuhide Takahashi.   

Abstract

Cell shape and adhesion of cultured mammalian cells change dramatically during mitosis, however, how cell cycle-dependent alterations in cell adhesion are regulated remain to be elucidated. We show here that normal human mammary epithelial (HME) cells which became less adhesive and adopted the rounded morphology during the G(2)/M phase of the cell cycle significantly reduced their dependence on beta1 integrin-mediated adhesion to laminin, by using function blocking antibody to beta1 integrin. In G(2)/M cells, both total and cell surface expressions of beta1 integrin were comparable with those in G(1) cells but it was phosphorylated at threonines 788-789 within its cytoplasmic domain and coimmunoprecipitated Ca(2+)/calmodulin-dependent protein kinase (CaMK) II. The threonine phosphorylated beta1 integrin significantly reduced its intracellular linkage with actin, with no significant reduction in the actin expression. In contrast, beta1 integrin in G(1) cells was not threonine phosphorylated but formed a link with actin and coimmunoprecipitated the core enzyme of the serine/threonine protein phosphatase (PP) 2A. The results suggest that reduced beta1 integrin-mediated cell adhesion of HME cells to the substratum during mitosis may be induced by beta1 integrin phosphorylation at threonines 788-789 and its reduced ability to link with the actin cytoskeleton. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14502569     DOI: 10.1002/jcp.10354

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  13 in total

1.  Specific phosphorylations transmit signals from leukocyte β2 to β1 integrins and regulate adhesion.

Authors:  Liisa M Uotila; Farhana Jahan; Laura Soto Hinojosa; Emiliano Melandri; Mikaela Grönholm; Carl G Gahmberg
Journal:  J Biol Chem       Date:  2014-10-02       Impact factor: 5.157

Review 2.  Pathways of integrins in the endo-lysosomal system.

Authors:  Márton Molnár; Ármin Sőth; Zsófia Simon-Vecsei
Journal:  Biol Futur       Date:  2022-05-02

3.  Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; George J Christ; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2008-03-12       Impact factor: 5.911

4.  CaMK-II promotes focal adhesion turnover and cell motility by inducing tyrosine dephosphorylation of FAK and paxillin.

Authors:  Charles A Easley; Claire M Brown; Alan F Horwitz; Robert M Tombes
Journal:  Cell Motil Cytoskeleton       Date:  2008-08

5.  PPM1F controls integrin activity via a conserved phospho-switch.

Authors:  Tanja M Grimm; Nina I Dierdorf; Karin Betz; Christoph Paone; Christof R Hauck
Journal:  J Cell Biol       Date:  2020-12-07       Impact factor: 10.539

Review 6.  Coupling changes in cell shape to chromosome segregation.

Authors:  Nitya Ramkumar; Buzz Baum
Journal:  Nat Rev Mol Cell Biol       Date:  2016-06-29       Impact factor: 94.444

7.  Cdk1 phosphorylation negatively regulates the activity of Net1 towards RhoA during mitosis.

Authors:  Arzu Ulu; Wonkyung Oh; Yan Zuo; Jeffrey A Frost
Journal:  Cell Signal       Date:  2021-01-17       Impact factor: 4.315

8.  WAVE2 Protein Complex Coupled to Membrane and Microtubules.

Authors:  Kazuhide Takahashi
Journal:  J Oncol       Date:  2012-01-18       Impact factor: 4.375

9.  TP53 transcription factor for the NEDD9/HEF1/Cas-L gene: potential targets in Non-Small Cell Lung Cancer treatment.

Authors:  Bénédicte Rousseau; Catherine Jacquot; Julie Le Palabe; Marine Malleter; Christophe Tomasoni; Tifenn Boutard; Vehary Sakanyan; Christos Roussakis
Journal:  Sci Rep       Date:  2015-05-26       Impact factor: 4.379

Review 10.  Micro- and nanodevices integrated with biomolecular probes.

Authors:  Yunus Alapan; Kutay Icoz; Umut A Gurkan
Journal:  Biotechnol Adv       Date:  2015-09-10       Impact factor: 14.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.